Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Snowshoe who wrote (175723)	8/4/2021 7:04:47 PM
From: TobagoJack	Read Replies (1) \| Respond to of 218879

Re <<Covid-19 items from Pfizer's recent Q2 earnings call... 1) Will apply for EUA (emergency use authorization) on booster dose. 2) Will start an immunogenicity and safety study on updated vaccine for the Delta variant. 3) Have started Phase 2/3 trial of orally administrated protease inhibitor treatment drug. >> 'they' might as well give the task to a bunch of kids to do because once completed by whomever, the virus should have burned through a few more alphabets, therefore no point in tying up qualified scientists on a thankless task. It might just be the case that BioNTech vaccine is a meme vaccine. In the case of Israel, a domain infused in BioNTech, all numbers heading up, and new cases more than same time last year, with unknown accumulation of vaccine issues within the population via what could well be a proto-placebo by the time the coming flu season is on. The not-yet-known is just how bad the virus itself is, and shall prove to be. Need a cure, and faster.